Homologous recombination deficiency should be tested for in patients with advanced stage high-grade serous ovarian cancer aged 70 years and over.
Saved in:
| Title: | Homologous recombination deficiency should be tested for in patients with advanced stage high-grade serous ovarian cancer aged 70 years and over. |
|---|---|
| Authors: | Pitiyarachchi, Omali1 (AUTHOR), Ansell, Peter J.2 (AUTHOR), Coleman, Robert L.3 (AUTHOR), Dinh, Minh H.2 (AUTHOR), Holman, Laura4 (AUTHOR), Leath III, Charles A.5 (AUTHOR), Werner, Theresa6 (AUTHOR), DiSilvestro, Paul7 (AUTHOR), Morgan, Mark8 (AUTHOR), Tew, William9 (AUTHOR), Lee, Christine10 (AUTHOR), Cunningham, Mary11 (AUTHOR), Newton, Meredith12 (AUTHOR), Edraki, Babak13 (AUTHOR), Lim, Peter14 (AUTHOR), Barlin, Joyce15 (AUTHOR), Spirtos, Nicola M.16 (AUTHOR), Tewari, Krishnansu S.17 (AUTHOR), Edelson, Mitchell18 (AUTHOR), Reid, Thomas19 (AUTHOR) |
| Source: | Gynecologic Oncology. Aug2024, Vol. 187, p221-226. 6p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
